ONI’s $75 Million Series B Funding Round

Wilson Sonsini Goodrich & Rosati advised ONI on the deal.ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now